Skip to main content
. 2018 Dec 30;21(4):307–309. doi: 10.5770/cgj.21.323

Table 1.

Summary of neurotoxicity cases from ingestion of bismuth subsalicylate

Reference Age Sex Bismuth Dose Bismuth Duration Manifestations Bismuth Level and Outcome
Hasking & Duggan (1982)(13) 60 M Unknown “… some years” Withdrawn, inappropriate & twitching x mth then dysarthria, disorientation, incontinence x2, twitches & primitive reflexes High blood level; full recovery in mth
Mendelowitz et al. (1990)(14) 45 M 5.2–9.4 g/d (AIDS patient with diarrhea(24) 7 days Lethargy, dysarthria, & myoclonic jerking that progressed to coma with myoclonus High blood & urine levels; death
Jungreis & Schaumburg (1993)(15) 68 F 1.2 g/d 2 yrs Intention/rest tremor, myoclonic jerks, unsteady gait, forgetfulness & episodic confusion Blood level high 6 wks after stopping; recovery in 6 mths
Gordon et al. (1995)(16) 54 M 1–4 g/d with recent increase Took for “… many years” Progressive confusion, memory difficulty, myoclonic jerks, tremor & unsteady gait Blood & urine levels high 35 days after stopping; improved over 12 wks
Reynolds et al. (2012)(17) 56 F 2.3 g/d with recent increase 2 mths Psychomotor retardation, poor concentration, drowsy, visual hallucinations, tremor, myoclonic jerks, & postural instability High blood & urine levels; recovery within several mths
Masannat & Nazer (2013)(18) 56 F 2.3 g/d Unclear (abstract stated mths but text indicates several wks) Progressive confusion, poor concentration, myoclonic jerks, tremors, gait instability, and visual hallucinations High blood level days after stopping; complete recovery in 4 mths
Siram et al. (2017)(19) 25 F Unclear but high dose – 8 tablets Q2 hr. 15–20 days Tinnitus/hearing loss (likely concurrent salicylate toxicity) progressing to altered sensorium Elevated blood level 20 d after stopping; improved over 2 mths

M = Male; F = Female.